Connection

Dao Wang to Cardiovascular Diseases

Back to Details
This is a "connection" page, showing publications Dao Wang has written about Cardiovascular Diseases.
Dao Wang
Connection Strength
0.407
Cardiovascular Diseases
  1. Cardiovascular molecular mechanisms of disease with COVID-19. J Mol Cell Cardiol. 2020 04; 141:107.
    View in: PubMed
    Score: 0.141
  2. Effect of white-coat hypertension on arterial stiffness: A meta-analysis. Medicine (Baltimore). 2018 Oct; 97(42):e12888.
    View in: PubMed
    Score: 0.127
  3. The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients. J Cell Mol Med. 2020 09; 24(18):10274-10278.
    View in: PubMed
    Score: 0.036
  4. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020 09; 17(9):543-558.
    View in: PubMed
    Score: 0.036
  5. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacol Ther. 2020 11; 215:107628.
    View in: PubMed
    Score: 0.036
  6. Serum vitamin D deficiency and vitamin D receptor gene polymorphism are associated with increased risk of cardiovascular disease in a Chinese rural population. Nutr Res. 2019 01; 61:13-21.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.